Necitumumab (Portrazza)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Necitumumab (Portrazza), covering 2016-06-27 to 2016-06-27. Get the full timeline:
Most recent: Clinical Trial Update: First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin [Phase 3]